When: Tuesday, 5.11.2019, 3pm to 5:25 p.m. (till 7 for hard networkers)
Where: Mannheim University of Applied Sciences, Karl-Völker-Saal, 4th floor, building A, Speyerer Straße 2-4, 68163 Mannheim

Tuesday, November 5, 2019 and come to our biannual exchange of Solutions for Challenges in Bioanalytics of Biopharmaceuticals incl. short impulse talks.
     
We are very happy to welcome the following speakers of the health industry at our event:

1. Dr. Soraya Hölper, Sanofi, Frankfurt
2. Dr. Thomas Schirrmann, CEO, Yumab GmbH, Braunschweig
3. Prof. Dr. Peter Findeisen, MVZ Labor Dr. Limbach & Kollegen, Heidelberg
4. Dr. Christian Albers (requested), Bruker Daltonik GmbH, Bremen

If you would like to register immediately, please send us an e-mail: m2aind@hs-mannheim.de

More information will follow shortly.

When: April 4 I 9:30am – 2:15pm
Where: Conference Center Technology Park, Im Neuenheimer Feld 582, Heidelberg

This event will focus on key considerations for transitioning a molecule from discovery to phase 1 readiness including API and formulation development, pharmacokinetics, quality and CMC requirements, and incorporation of clinical supply services solutions to meet protocol, clinical site and patient needs.

Here you will find the Programm. More information will be available here.

Please register for the free Seminar here.

Following the meeting, all Catalent speakers and executives will be available for private, no-obligation discussions on specific programmes and challenges. To request an appointment, please contact Annalisa Zuccotti (az@biorn.org).

Note: M²Aind is not involved in this event. This is an announcement of the event.

When: Tuesday, 2.4.2019, 3pm to 6pm
Where: Merck KGaA, Frankfurter Str. 250, 64293 Darmstadt

In person and on behalf of our co-organizer Merck KGaA, we cordially invite you to our second event biannual Exchange of Solutions for Challenges in Bioanalytics of Biopharmaceuticals with Keynote Speeches in the Bioanalytics of Biopharmaceuticals Division.

We present you

Short talks

• Dr. Friedrich Reinhard, Cellzome, a GSK Company - Chemoproteomics and Thermal Protein Profiling in Target Discovery and Validation
• Dr. Christian Lutz, Heidelberg Pharma Research GmbH - Analytical characterization of antibody-amatoxin conjugates (ADCs)
• Dr. Sibylle Heidelberger, AB Sciex Germany GmbH - Development of High Throughput Online Native LC/MS

Please register until March 18th, 2019 at the following e-mail address: m2aind@hs-mannheim.de. Further details will be provided after your registration. We would be very pleased about your participation.

Join several industry leaders from top pharma companies and academia around the globe as they present their  perspectives on using advanced MS and SPR based  technologies to streamline the drug development process. From lead generation all  the way through to pre-clinical assessment, Bruker has built on years of excellence in Mass Spectrometry to impact the pharmacological  related industry far beyond the traditional role of quantitation and process monitoring.

Seminar sessions
March 18, 2019 // 9.30 am - 6.30 pm
rapifleX MALDI Pharma Pulse, timsTOF Pro (trapped ion mobility) and SPR-32 (surface plasmon resonance) applications in Pharma
March 19, 2019 // 9 am - 4 pm
MS Imaging Applications in Pharma

Get more information here.

We are pleased that the M²Aind Talk is taking place outside the home for the first time and that we will be guests at the IHK Rhein-Neckar in Heidelberg. We would like to thank the IHK Rhein-Neckar for their support and hospitality. At this M²Aind Talk, the three keynote speeches - based on the SM²all impulse project - deal with the subject of chemical analysis with ion mobility spectrometry and drug testing in assays.
 

Program:

4 p.m. reception

4.30 p.m. welcome

4.40 p.m. Lectures:

GC-IMS – Selective trace gas analysis of volatile compounds in industrial applications
Thomas Wortelmann, G.A.S. Gesellschaft für analytische Sensorsysteme mbH
Approaches to the quantification of terpenes from complex mixtures using two-dimensional GC-IMS und MCR-ALS
Prof. Dr. Philipp Weller / Rebecca Brendel, Innovationspartnerschaft M²Aind
Discovery of potent inhibitors of the hepatic & intestinal drug transporter OATP2B1 through a cell based fluorescence assay
Melissa Unger, Innovationspartnerschaft M²Aind, Mannheim University of Applied Sciences

17.30 Uhr            Networking with finger food and drinks
Ca. 19.00 Uhr     End of the event

Please register by February 10, 2019 at the following email address: m2aind@hs-mannheim.de
 
Address:
IHK Rhein-Neckar
Theodor Frey Saal
Hans-Böckler-Straße 4
69115 Heidelberg

Please note that the IHK Rhein-Neckar does not offer any parking facilities. However, there are numerous parking garages nearby. The IHK Rhein-Neckar can also be easily reached by public transport. You will find a map of how to get there here

Park:
Parking garage Poststraße, Poststraße 7-9, 69115 Heidelberg
Parking garage Bauhaus, Bahnhofstraße 4, 69115 Heidelberg
Parking garage Europäischer Hof, Friedrich-Ebert-Anlage 1, 69117 Heidelberg

Arrival by public transport: You can reach us by all means of public transport: Bismarckplatz stop

When: Tuesday, 9.10.2018, 4pm to 7pm
Where: Mannheim University of Applied Sciences, Karl-Völker-Saal, 4th floor, building A, Speyerer Straße 2-4, 68163 Mannheim

• 4:00 pm - Networking with coffee and cake
• 4:30 pm - Welcome and introduction to the topic Bioanalytics of Biopharmaceuticals and Introduction M²Aind, Dr. Roland Kellner Merck KGaA, Darmstadt and Prof. Dr. Carsten Hopf, Center forMass Spectrometry and Optical Spectroscopy (CEMOS)
• 4:45 pm - ADCs: Searching for the magic bullet | Dr. Jan Anderl, Merck KGaA, Darmstadt
• 5:10 pm - Developing First-In-Class Immune Cell Engagers for the Activation of Innate and Adaptive Immunity to Fight Cancer, Thomas Müller, Affimed GmbH, Heidelberg
• 5:35 pm- LC-MALDI analysis of biopharmaceuticals: A real strange idea or a solution to current issues with potential? Dr. Detlev Suckau, Bruker Daltonik GmbH, Bremen
• 5:50 pm - Networking with food and drinks

Please register atm2aind@hs-mannheim.de

On April 17, 2018, the M²Aind innovation partnership organized the 2nd M²Aind Talk. This is a get-together for the health industry for the greater Rhine-Main-Neckar area.

There were three keynote speeches on the subject of "Process Development and Process Analytics":

• Intro: Herr Dr. Siegfried Bialojan, Ernst & Young GmbH
• Herr Stefan Bley, Ernst & Young GmbH, Industry 4.0 – Smart Production
• Herr Prof. Dr. Thorsten Röder, Mannheim University of Applied Sciences, Multiphase reaction in microreactors
• Herr Thomas Müller und Herr Ralf Stegemann, EM-Technik GmbH, Innovation in plastic

We would like to thank the E&Y Wirtschaftsprüfungsgesellschaft for their kind support.

Bruker Daltonics and the M2Aind Partnership for Innovation in Health Industry are organizing a two-day workshop on “MALDI Innovations in Pharma”, which shall take place on Feb 21st/22nd in Mannheim.
The first day will focus onrapifleX PharmaPulse – MALDI MS-based assays for compound profiling incl HTS. Day 2 will feature current applications in pharma industry and in chemical biology.

Please, register via the Bruker website.

Seminar Sessions

February 21: rapifleX MALDI PharmaPulse: reset your expectation for label-free high-throughput-screening utilizing mass spectrometry

February 22: MS Imaging Applications in Pharma and Chemical Biology

The M²Aind Talk is a get-together of the health industry for the greater Rhine-Neckar-Main area. Representatives of the regional health industry use the opportunity to exchange ideas and learn new things from the industry.

Where: Karl Völker Saal, Building A, Mannheim University of Applied Sciences

When: November 20, 2017 from 4 p.m. to 7 p.m.

Exciting keynote speeches await you:
- Prof. Dr. Marcus Rieker - Horiba Europe GmbH
- Prof. Dr. Matthias Rädle, M2Aind - Mannheim University of Applied Sciences
- Prof. Dr. Carsten Hopf, M2Aind - Mannheim University of Applied Sciences

Program items

4:00 p.m. reception and start

4.30 p.m. Welcome and short talks

5.30 p.m. Networking

Please register at the following email address: m2aind@hs-mannheim.de

This year's BioRN annual conference on October 24th, 2017, once again offers a varied program and numerous networking opportunities. In addition to specialist presentations on the conference topic, BioRN members have the opportunity to present their project or company in short presentations. The program is rounded off by a poster exhibition.

The previously confirmed speakers are:

    Clemens Suter-Crazzolara (SAP)

    Elmar Bourdon (Medtech Cluster Mannheim)

    Nico Stam (Health Axis Europe Partner, Brightlands Maastricht Health Campus)

    Gitte Neubauer (Cellzome, a GSK company)

    Andrée Rothermel (Ci3)

    Kai Gräber (Ci3)

    Wulf Fischer-Knuppertz (BIOCRATES Life Sciences AG)

    Prof. Carsten Hopf (Hochschule Mannheim)

    Prof. Rüdiger Rudolf  (Hochschule Mannheim)

You can find more information about the event here.